We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.
ARTICLE · 17 NOVEMBER 2017
FTC Workshop Signals Continued Focus on Prescription Drug Competition

Arnold & Porter
Contributor

Arnold & Porter
With over 1,000 lawyers across 16 offices worldwide, Arnold & Porter is renowned for its...
View firm profileThe FTC's stated purpose for its workshop was to study the barriers to generic drug competition and whether other market forces create inefficiencies that lead to higher drug prices.
United StatesAntitrust/Competition Law











